Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Sexually Transmitted Diseases

Sexually Transmitted Diseases

ADVERTISEMENT
News and Trends

Intravacc to develop intranasal gonorrhea vaccine with $14.6M NIH/NIAID contract

Intravacc has been awarded a contract with base and options that may total US$14.6 million…

By Jim Cornall
October 5, 2022 - 3 minutes
Startup Scout

A Norwegian Biotech is Aiming at Permanently Removing HPV Skin Infections

This week we're traveling to Bergen, a beautiful coastal city in Norway surrounded by seven…

By Clara Rodríguez Fernández
July 7, 2017 - 2 minutes
News and Trends

Results are in for Europe’s First Biobanking Study on HPV Cervical Cancer

The RAIDs consortium made its closing event last week. After 4.5 years of studies, it…

By Timothé Cynober
June 14, 2017 - 5 minutes
News and Trends

€4M Grant for a Cancer Vaccine that could Bench its Competitors

Hookipa just secured a huge grant from the Austrian government. The plan is to develop…

By Clara Rodríguez Fernández
October 18, 2016 - 2 minutes
News and Trends

Transgene teams up with big Players against HPV Head and Neck Cancer

Transgene is partnering with Merck and Pfizer to develop a combined therapy for head and…

By Clara Rodríguez Fernández
October 12, 2016 - 3 minutes
News and Trends

After its drop earlier this year, Genticel goes back up the slope

Genticel has announced that not one but two milestones have been achieved in the development…

By Jerome Topsent
June 17, 2016 - 3 minutes
News and Trends

Genticel is vaccinating against Cervical Cancer AFTER Infection

Estonia, our previous destination by the Baltic Sea, was a delightful and a full of…

By Joachim Eeckhout
June 10, 2016 - 2 minutes
News and Trends

Viral Immunotherapy Trial Failure Causes French Biotech Stocks to Drop 43%

Genticel (France) is a clinical biotech developing a cervical cancer immunotherapy against the Human papillomavirus. However, their 24-month phase…

By Dani Bancroft
January 28, 2016 - 3 minutes
News and Trends

The Assault on Solid Tumors: How ‘Blinding’ Cancer is an Attractive Therapeutic Approach

The Dutch Oncology VC Specialist Aglaia has invested €3.4M in the Swiss Start-Up Inthera Bioscience…

By Dani Bancroft
December 17, 2015 - 3 minutes
News and Trends

Genticel aims to prevent Cancer caused by the Human Papillomavirus

Genticel is a step closer to prevent cancer caused by the human papillomavirus (HPV). The…

By Lourdes Riquelme
June 2, 2015 - 2 minutes
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days